Price of NBIX with the Market Cap of SMMT

If Neurocrine Biosciences, Inc. (NBIX) had the market cap of Summit Therapeutics Inc. (SMMT), one NBIX would cost $140.60, 16.73% less than today's price of $168.86. The market cap of Neurocrine Biosciences, Inc. ($17.09B) is 1.20 times that of Summit Therapeutics Inc. ($14.23B).

Result

With The Market Cap of

$140.60
(0.83x)

NBIX is 1.20x above SMMT

NBIX.US Market Cap
NBIX.US M. Cap:
$17,091,840,340
SMMT.US Market Cap
SMMT.US M. Cap:
$14,231,860,000
Wonder your profit?
Estimated value:
$0.00
NBIX
NBIX is 1.20x above SMMT
NBIX.US Market Cap
NBIX.US M. Cap:
$17,091,840,340
SMMT.US Market Cap
SMMT.US M. Cap:
$14,231,860,000

Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this

Neurocrine Biosciences, Inc. vs Summit Therapeutics Inc.: key figures

Neurocrine Biosciences, Inc. NBIX Summit Therapeutics Inc. SMMT
Rank #1318 #1537
Price $168.86 $17.84
Market cap $17.09B $14.23B
Shares Outstanding 101.22M 797.75M
Change (1 day) +2.57% +9.25%
Change (1 year) +17.13% -2.30%

The other way round: SMMT with the market cap of NBIX

$21.43 (1.20x)

If Summit Therapeutics Inc. (SMMT) had the market cap of Neurocrine Biosciences, Inc. (NBIX), one SMMT would cost $21.43, 1.20 times today's price of $17.84.

Price of SMMT with the Market Cap of NBIX

Price of NBIX with the Market Cap of SMMT: the last 12 months

The price of one NBIX if Neurocrine Biosciences, Inc. had the market cap of Summit Therapeutics Inc., at the end of each month. Highest: $167.25 (Apr 2026). Lowest: $101.47 (Jul 2026).

  1. $134.85 Dec 2025
  2. $111.64 Jan 2026
  3. $129.29 Feb 2026
  4. $147.77 Mar 2026
  5. $167.25 Apr 2026
  6. $135.81 May 2026
  7. $112.82 Jun 2026
  8. $101.47 Jul 2026
  9. $108.06 Aug 2026
  10. $134.16 Sep 2026
  11. $125.80 Oct 2026
  12. $140.60 Nov 2026

Questions about Neurocrine Biosciences, Inc. and Summit Therapeutics Inc.

What would the price of Neurocrine Biosciences, Inc. be with the market cap of Summit Therapeutics Inc.?

If Neurocrine Biosciences, Inc. (NBIX) had the market cap of Summit Therapeutics Inc. (SMMT), one NBIX would cost $140.60, 16.73% less than today's price of $168.86.

How much bigger is Neurocrine Biosciences, Inc. than Summit Therapeutics Inc.?

The market cap of Neurocrine Biosciences, Inc. ($17.09B) is 1.20 times that of Summit Therapeutics Inc. ($14.23B). In Dec 2025 the gap was 1.05 times.

What would the price of Summit Therapeutics Inc. be with the market cap of Neurocrine Biosciences, Inc.?

If Summit Therapeutics Inc. (SMMT) had the market cap of Neurocrine Biosciences, Inc. (NBIX), one SMMT would cost $21.43, 1.20 times today's price of $17.84.

How is this price calculated?

The market cap of Summit Therapeutics Inc. ($14.23B) is divided by the number of NBIX in circulation (101.22M). Market cap is the price multiplied by the number of coins or shares in circulation.